Breast Cancer Prevention Drug Anastrozole to be Offered to Almost 300,000 Women in England

Anastrozole, the newly licensed drug that has previously been used to treat breast cancer, is now set to be offered as a preventative measure to high-risk postmenopausal women in England, potentially preventing 8,000 cases of disease and saving the NHS £15 million.